Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients

Summary

In Tunisia, high blood pressure (HTN) is a public health problem whose prevalence varies from 28.7% to 34.7%. Hypertension can be both, cause and consequence of chronic kidney disease, and its prevalence is quite high in this population. It is both a risk factor for mortality and cardiovascular morbidity, but also a major cause of terminal chronic kidney disease becoming an additional public health concern.

Detecting and diagnosing chronic kidney in all hypertensives at an early stage remains a global public health challenge. A well-conducted treatment makes it possible to reach the blood pressure objective but also to reduce the risk of occurrence of a cardiovascular event and to slow the progression of chronic kidney disease.

In Tunisia, few data exists concerning the prevalence of chronic kidney disease in hypertensive subjects, thus limiting the development and elaboration of preventive measures. A national survey will thus be conducted by the "Kidney and Metabolic Diseases" Working Group under the aegis of the Tunisian Society of Nephrology, Dialysis and Kidney Transplantation. The main objective is to estimate the prevalence of chronic kidney disease in hypertensive tunisian patients.

Conditions

• Chronic Kidney Diseases
• Hypertension

Sponsors & Collaborators

• Tunisian Society for Nephrology, Dialysis and Renal Transplantation

  collaborator UNKNOWN

• Dacima Consulting

  lead OTHER

Principal Investigators

• Jannet Labidi, MD · Military Hospital of Tunis (Tunis, Tunisia)

• Amel Harzallah, MD · University Hospital of Charles Nicolle (Tunis, Tunisia)

• Awatef Azzabi, MD · University Hospital of Sahloul (Sousse, Tunisia)

• Badreddine Ben Kaab, MD · La Marsa Internal Security Forces Hospital (Tunis, Tunisia)

• Ikram Mami, MD · University Hospital of La Rabta (Tunis, Tunisia)

• Lamia Rais, MD · University Hospital of La Rabta (Tunis, Tunisia)

• Maissa Hadji Brahim, MD · University Hospital of Taher Sfar (Mahdia, Tunisia)

• Mouna Hammouda, MD · University Hospital of Fattouma Bourguiba (Monastir, Tunisia)

• Sahar Agrebi, MD · University Hospital of Charles Nicolle (Tunis, Tunisia)

• Seifeddine Azaiez, MD · Private Clinic (Ben Arous, Tunisia)

• Soumaya Chargui, MD · University Hospital of Charles Nicolle (Tunis, Tunisia)

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-01-08

Primary Completion

2024-07-01

Completion

2024-07-01

Countries

• Tunisia

Study Locations